[Karamedica, Inc. and Murrieta Genomics are the first two tenants to move into UC Riverside's recently opened Life Sciences Incubator, the first wetlab space for biotech entrepreneurs in the Inland Empire.]
Murrieta Genomics Spinout simplSEQ to Present Novel Multi-Omic Technology at Sequencing, Finishing and Analysis in the Future Meeting prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Follow US:
New startups developing health and diagnostic technologies May 11, 2021 May 11, 2021
Two new tenants have joined the UC Riverside Life Sciences Incubator as the campus continues to ramp-up research and provide lab and office space for life science entrepreneurs.
NeyroblastGX and GattaCo Inc. are the third and fourth tenants to join the state-of-the-art research facility housed in the Multidisciplinary Research Building. Karamedica Inc. and Murrieta Genomics Inc. were the first two tenants in the incubator, which is managed by the UC Riverside Office of Technology Partnerships.
NeyroblastGX, which was founded last year, began working out of the incubator in January and has received funding from the U.S. Department of Defense, Defense Advanced Research Projects Agency, and the National Science Foundation.
Murrieta (PRWEB) April 21, 2021 Murrieta Genomics, the launch pad for genomic sequencing startups, has announced that simplSEQ, an incubator company, has
Dr. John C. Spinosa Joins Murrieta Genomics as Chief Medical Officer
Share Article
Addition of noted pathologist to executive team provides insights into precision medicine and critical connections to the greater life science community.
Dr. John C. Spinosa MURRIETA, Calif. (PRWEB) February 02, 2021
Murrieta Genomics, the launch pad for genomic sequencing startups, has announced that John C. Spinosa, M.D., Ph.D., has joined the executive management team. He has also been appointed as Chief Medical Officer of SimplSEQ, Inc., a wholly owned subsidiary of Murrieta Genomics.
“We are fortunate to have attracted Dr. Spinosa to join us,” stated Jay Goth, CEO. “John’s background and experience with companies large and small will be critical to our future success helping genomic sequencing companies revolutionize the healthcare, agriculture and forensic industries. His reputation as a leading pathologist is well